Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy

Journal of Urology

Volumn 159, Issue 3, 1998, Pages 641-649

  Prins, Gail S ^a   Sklarew, Robert J ^a   Pertschuk, Louis P ^a  

^a NONE

Author keywords

Androgen; Hormones; Prostatic neoplasms; Receptors

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; GROWTH REGULATION; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; TRANSCRIPTION REGULATION;

EID: 0031932638     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63692-9     Document Type: Article

References (21)

1. Catalona, W. J. and Scott, W. W.: Carcinoma of the prostate. In: Campbell's Urology. Edited by P. C. Walsh, R. F. Gittes, A. D. Perlmutter and T. A. Stamey. Philadelphia: W.B. Saunders Co., vol. 2, chapt. 32, pp. 1463-1534, 1986.
2. Brolin, J., Skoog, L. and Ekman, P.: Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate, 20: 281, 1992.
3. Ruizeveld de Winter, J. A., Janssen, P. J. A., Sledeens, H. M. E. B., Verleun-Mooijman, M. C. T., Trapman, J., Brinkmann, A. O., Santerse, A. B., Schroder, F. H. and van der Kwast, T. H.: Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Amer. J. Path., 144: 735, 1994.
4. Sadi, M., Walsh, P. and Barrack, E.: Immunohistochemical study of androgen receptors in metastatic prostate cancer. Cancer, 67: 3057, 1991.
5. Chodak, G., Kranc, D., Puy, L., Takeda, H., Johnson, K. and Chang, C.: Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. J. Urol., 147: 798, 1992.
6. Kimura, N., Watanabe, M., Kubota, M., Oonuma, T., Mizokami, A. and Nagura, H.: Quantitative analysis of immunohistochemical androgen receptor and Ki-67 in prostatic carcinoma and its relationship to histologic grade. Oncol. Report, 1: 69, 1994.
7. Takeda, H., Akakra, K., Masai, M., Akimoto, S., Yatani, R. and Shimazaki, J.: Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma. Cancer, 77: 934, 1996.
8. Miyamoto, K. K., McSherry, S. A., Dent, G. A., Sar, M., Wilson, E. M., French, F. S., Sharief, Y. and Mohler, J. L.: Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue. J. Urol., 149: 1015, 1993.
9. Pertschuk, L. P., Schaeffer, H., Feldman, J. G., Macchia, R. J., Kim, Y. D., Eisenberg, K., Braithwaite, L. V., Axiotis, C. A., Prins, G. and Greene, G. L.: Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with a poor prognosis. Lab. Invest., 73: 302, 1995.
10. Pertschuk, L. P., Macchia, R. J., Feldman, J. G., Brady, K. A., Levine, M., Kim, D., Eisenberg, K. B., Rainford, E., Prins, G. S. and Greene, G. L.: Immunocytochemical assay for androgen receptors in prostate cancer: a prospective study of 63 cases with long-term follow-up. Ann. Surg. Oncol., 1: 495, 1994.
11. van der Kwast, T. H., Schalken, J., Ruizeveld de Winter, J. A., van Vroonhoven, C. J., Mulder, E., Boersma, W. and Trapman, J.: Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int. J. Cancer, 48: 189, 1991.
12. Klocker, H., Culig, Z., Hobisch, A., Cato, A., C. B. and Bartsch, G.: Androgen receptor alterations in prostatic carcinoma. Prostate, 25: 266, 1994.
13. Sadi, M. and Barrack, E.: Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Cancer, 71: 2574, 1993.
14. Tilley, W., Lim-Tio, S., Horsfall, D., Aspinall, J., Marshall, V. and Skinner, J.: Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res., 54: 4096, 1994.
15. Sklarew, R., Bodmer, S. and Pertschuk, L.: Quantitative imaging of immunocytochemical (PAP) estrogen receptor staining patterns in breast cancer sections. Cytometry, 11: 359, 1990.
16. Sklarew, R., Bodmer, S. and Pertschuk, L.: Comparison of microscopic imaging strategies for evaluating immunocytochemical (PAP) steroid receptor heterogeneity. Cytometry, 12: 207, 1991.
17. Schmidt, J. D. and Scott, W. W.: Chemotherapy of advanced prostatic cancer, evaluation of response parameters. Urology, 7: 602, 1976.
18. Shi, S. R., Chaiwun, B., Young, L., Cote, R. J. and Taylor, C. R.: Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J. Histochem. Cytochem., 41: 1599, 1993.
19. Prins, G. S., Birch, L. and Greene, G. L.: Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology, 129: 3187, 1991.
20. Sklarew, R. J. and Pertschuk, L. P.: Quantitation of the immunocytochemical assay for estrogen receptor protein (ER-ICA) in human breast cancer by television imaging. J. Histochem. Cytochem., 35: 1253, 1987.
21. Pertschuk, L. P., Feldman, J. G., Kim, Y. D., Braithwaite, L., Schneider, F., Braverman, A. S. and Axiotis, C.: Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spgamma in frozen sections or cytosol-based ligand-binding assays. Cancer, 77: 2514, 1996.